The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent ...

In another Gazzette notification, the drug pricing regulator fixed the retail price of 20 new drugs under the provisions of ...

India's drug pricing authority has increased the prices of essential drugs for conditions like asthma and tuberculosis, ...

India's drug pricing authority has hiked the prices of drugs for conditions like asthma, tuberculosis, and mental health.

The government has increased the cost of certain essential drugs for treating asthma, tuberculosis and others.

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

The Indian government has approved a 50% increase in the ceiling prices of several essential drugs used to treat various conditions, due to increased costs and unviability issues. The National ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Ceiling prices were also revised for the asthma drug Salbutamol in tablets of 2 mg and 4 mg formulations and respirator ...

NPPA approves 50% increase in ceiling prices for essential drugs to ensure affordability and availability for public health.